China Biopharmaceutical (01177): TQB2102 "HER2 Bispecific Epitope ADC" to Present Two Clinical Data Sets at 2026 ESMO

Zhitong Finance APP News, Sino Biopharmaceutical (01177) announced that TQB2102 "HER2 bispecific epitope ADC", a National Class 1 innovative drug independently developed by the Company's subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Chia Tai Tianqing), was presented at the 2026 European Society for Medical Oncology (ESMO) Annual Congress, where two sets of clinical data were released and selected respectively for the Congress's Proffered Paper (LBA) and Rapid Oral presentations.